Status:
UNKNOWN
Intranasal Insulin for Prevention of Type 1 Diabetes
Lead Sponsor:
University of Turku
Collaborating Sponsors:
Oulu University Hospital
Tampere University
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
1-15 years
Phase:
PHASE3
Brief Summary
Children born in Turku, Oulu and Tampere university cities in Finland are screened at birth for HLA alleles that carry increased risk to or protection from development of type 1 diabetes. Children car...
Detailed Description
Children born in Turku, Oulu and Tampere university cities in Finland are screened at birth for the HLA-DQB1 and DQA1 alleles that carry increased risk to or protection from development of type 1 diab...
Eligibility Criteria
Inclusion
- children carrying HLA-conferred genetic risk for developing type 1 diabetes
- have had at least two types of autoantibodies of ICA, IAA, GADA and IA-2A in at least two consecutive blood samples drawn at least 3 months apart
- age at least one year
Exclusion
- severe other disease
- age above 15 years
Key Trial Info
Start Date :
August 1 1997
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00223613
Start Date
August 1 1997
End Date
August 1 2005
Last Update
September 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics, University of Turku
Turku, Finland, FI-20520